Black Diamond Therapeutics Inc (BDTX)
Healthcare
Biotechnology
1.70 $
-1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Black Diamond Therapeutics Inc (BDTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.5% of the shares are freely tradable; institutional investors hold 78.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
78.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
91.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
57Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Investment Management,Inc. | 18.43 | 10,563,103 | -18.4 | 03/31/2026 |
| NEA Management Company, LLC | 7.76 | 4,448,757 | +0.0 | 03/31/2026 |
| Acadian Asset Management LLC | 4.10 | 2,348,651 | +939,360.4 | 03/31/2026 |
| Vanguard Group Inc | 3.82 | 2,188,857 | +0.0 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.23 | 1,850,468 | +0.0 | 03/31/2026 |
| Renaissance Technologies Corp | 2.87 | 1,643,747 | +73.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock | 4.74 | 2,716,191 | +2.6 | 04/30/2026 |
| T. Rowe Price US Small-Cap Core Equity | 4.62 | 2,646,444 | -0.2 | 03/31/2026 |
| T. Rowe Price Small-Cap Value | 3.71 | 2,128,724 | -0.1 | 04/30/2026 |
| T. Rowe Price Instl Small-Cap Stock | 2.50 | 1,433,898 | +2.7 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.